ORAMED PHARMACEUTICALS INC. Quarterly Return On Assets in % from Q2 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from Q2 2012 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Return On Assets for the quarter ending June 30, 2024 was 9.94 %.
  • Oramed Pharmaceuticals Inc. annual Return On Assets for 2023 was 2.88 %.
  • Oramed Pharmaceuticals Inc. annual Return On Assets for 2022 was -22.1 %, a 25.1% increase from 2021.
  • Oramed Pharmaceuticals Inc. annual Return On Assets for 2021 was -29.6 %, a 2.54% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 9.94 +22.3 Apr 1, 2024 Jun 30, 2024
Q1 2024 5.15 +23.2 Jan 1, 2024 Mar 31, 2024
Q4 2023 2.88 +25 Oct 1, 2023 Dec 31, 2023
Q3 2023 -9.07 +14.9 +62.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -12.4 +12.1 +49.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18.1 +5.27 +22.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -22.1 +2.79 +11.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -24 +5.59 +18.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -24.5 +11.2 +31.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -23.3 +15.3 +39.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -24.9 +15.4 +38.2% Sep 1, 2021 Dec 31, 2021
Q3 2021 -29.6 +0.77 +2.54% Jul 1, 2021 Aug 31, 2021
Q2 2021 -35.6 +38.6 +52% Apr 1, 2021 Jun 30, 2021
Q1 2021 -38.6 +21.5 +35.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -40.3 -5.58 -16.1% Sep 1, 2020 Dec 31, 2020
Q3 2020 -30.3 +6.13 +16.8% Jun 1, 2020 Aug 31, 2020
Q2 2020 -74.3 -75.6 -5900% Mar 1, 2020 May 31, 2020
Q1 2020 -60.1 -41.2 -219% Dec 1, 2019 Feb 29, 2020
Q4 2019 -34.7 +0.65 +1.84% Sep 1, 2019 Nov 30, 2019
Q3 2019 -36.5 -5 -15.9% Jun 1, 2019 Aug 31, 2019
Q2 2019 1.28 +33.9 Mar 1, 2019 May 31, 2019
Q1 2019 -18.8 +6.72 +26.3% Dec 1, 2018 Feb 28, 2019
Q4 2018 -35.4 -9.75 -38% Sep 1, 2018 Nov 30, 2018
Q3 2018 -31.5 -6.09 -24% Jun 1, 2018 Aug 31, 2018
Q2 2018 -32.6 +6.41 +16.4% Mar 1, 2018 May 31, 2018
Q1 2018 -25.5 +4.78 +15.8% Dec 1, 2017 Feb 28, 2018
Q4 2017 -25.6 +1.97 +7.14% Sep 1, 2017 Nov 30, 2017
Q3 2017 -25.4 +5.65 +18.2% Jun 1, 2017 Aug 31, 2017
Q2 2017 -39.1 -25.2 -182% Mar 1, 2017 May 31, 2017
Q1 2017 -30.3 -1.76 -6.16% Dec 1, 2016 Feb 28, 2017
Q4 2016 -27.6 +4.81 +14.8% Sep 1, 2016 Nov 30, 2016
Q3 2016 -31 -0.89 -2.95% Jun 1, 2016 Aug 31, 2016
Q2 2016 -13.9 +31.6 +69.5% Mar 1, 2016 May 31, 2016
Q1 2016 -28.6 +1.88 +6.18% Dec 1, 2015 Feb 29, 2016
Q4 2015 -32.4 -4.46 -16% Sep 1, 2015 Nov 30, 2015
Q3 2015 -30.1 -0.15 -0.5% Jun 1, 2015 Aug 31, 2015
Q2 2015 -45.5 -91.7 -198% Mar 1, 2015 May 31, 2015
Q1 2015 -30.4 -67.4 -182% Dec 1, 2014 Feb 28, 2015
Q4 2014 -28 -87.2 -147% Sep 1, 2014 Nov 30, 2014
Q3 2014 -30 -94.4 -147% Jun 1, 2014 Aug 31, 2014
Q2 2014 46.2 +129 Mar 1, 2014 May 31, 2014
Q1 2014 37 +116 Dec 1, 2013 Feb 28, 2014
Q4 2013 59.2 +145 Sep 1, 2013 Nov 30, 2013
Q3 2013 64.4 +155 Jun 1, 2013 Aug 31, 2013
Q2 2013 -83.3 -2.72 -3.38% Mar 1, 2013 May 31, 2013
Q1 2013 -79.1 Dec 1, 2012 Feb 28, 2013
Q4 2012 -86.3 Sep 1, 2012 Nov 30, 2012
Q3 2012 -90.3 Jun 1, 2012 Aug 31, 2012
Q2 2012 -80.5 Mar 1, 2012 May 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.